High Performance (OTCMKTS:TBEV) Held Back by Dilution
On September 18, High Performance (OTCMKTS:TBEV)’s shareholders were finally given a reason to smile. The company’s long awaited Performance Punch was on the market and it was available for everyone to buy. That wasn’t the latest piece of good news to come out of the residential house that serves as TBEV‘s headquarters.
Ten days ago, the company announced that the initial inventory Amazon ordered had run out after just 48 hours which earned the Performance Punch a #1 Best Seller badge in the nutrition category. Put simply, TBEV‘s sports drink is turning out to be a roaring success.
Unfortunately, the same can not be said about the stock. TBEV is managing to keep its head above the $0.001 per share mark which was unthinkable until a few months ago, but that is hardly awe-inspiring considering the positive news.
Clearly, something is holding the stock back. Let’s see what.
As we mentioned already, the company headquarters seems to be located in a residential house which doesn’t exactly solidifies TBEV‘s credibility. In fact, this could be enough of a reason for some to simply walk away.
The latest 10-Q doesn’t really inspire any confidence, either. In fact, it’s pretty ugly:
- total assets: $308 thousand
- total liabilities: $4.1 million
- NO revenue
- quarterly operating loss: $283 thousand
These sort of results could also put you off and when you put the dilution into the equation, things start to look really nasty.
In February, TBEV effected a 1 for 10 reverse split which brought the O/S count down from around 2.1 billion all the way to 212 million. Then, the printing press was kicked into high gear. Lots of convertible debt was turned into shares and as a result, in June, just over three months after the split, the O/S count was back at over 2.2 billion. The number of authorized shares was raised to 5 billion recently and there was no shortage of convertible debt still outstanding when TBEV filed its latest report, so the chances of a higher O/S count at the moment are far from slim.
The people at the helm seem to realize what the problem is, however, and they appear to be determined to solve it. They have said time and again that they have borrowed absolutely no money under convertible note agreements since the beginning of the year, and they announced on Friday that they might just be able to pay off some of the currently outstanding toxic debt with cash.
An entity called GHS Capital has apparently agreed to extend a $5 million line of funding over the next two years and TBEV said that some of the money will be used for extinguishing outstanding notes. This definitely sounds nice. If the company manages to tidy up the balance sheet and if the dilution stops, the news might take the ticker sky-high.
At least that’s what people are hoping for. On Friday, their enthusiasm managed to push TBEV 20% up to a close of $0.0012. There is one thing missing, however.
The press release didn’t give us the actual terms of the equity line, but it did say that it is all dependent on an S-1 registration form which has yet to be filed. Filing and having an S-1 statement declared effective is not the easiest thing in the world. In fact, it often takes quite a lot of time and considering the huge amount of toxic debt TBEV has, time might not be abundant.
About thirty-five minutes after the opening bell, TBEV is sitting at $0.0011 (8% in the red).
